Circulating vitamin D metabolites and kidney disease in type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4780-4788

  De Boer, Ian H ^a   Sachs, Michael C ^a   Cleary, Patricia A ^b   Hoofnagle, Andrew N ^c   Lachin, John M ^b   Molitch, Mark E ^b   Steffes, Michael W ^d   Sun, Wanjie ^b   Zinman, Bernard ^e   Brunzell, John D ^f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYVITAMIN D; 25 HYDROXYVITAMIN D; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCITRIOL; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IOTALAMIC ACID;

ADULT; ARTICLE; COHORT ANALYSIS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLITE; MICROALBUMINURIA; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM;

ADULT; ALBUMINURIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INCIDENCE; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84870762049     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2852     Document Type: Article

References (36)

1. Parving HH, Oxenbøll B, Svendsen PA, Christiansen JS, Andersen AR 1982 Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 100:550-555 (Pubitemid 12089232)
2. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H 1982 Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432 (Pubitemid 12123979)
3. Mogensen CE 1984 Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360 (Pubitemid 14179541)
4. de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM 2011 Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171:412-420
5. de Boer IH, Kestenbaum B, Rue TC, Steffes MW, Cleary PA, Molitch ME, Lachin JM, Weiss NS, Brunzell JD 2008 Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med 168:1867-1873
6. Borch-Johnsen K, Kreiner S 1987 Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 294:1651-1654 (Pubitemid 17088017)
7. 1995 Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int 47:1703-1720
8. 2003 Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:2159-2167
9. de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B 2011 Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 365:2366-2376
10. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD 1993 The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462 (Pubitemid 23335891)
11. Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E 1998 Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 53:1696-1705 (Pubitemid 28243754)
12. Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, Doi T 2001 A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol 158:1733-1741 (Pubitemid 32422938)
13. Hirata M, Makibayashi K, Katsumata K, Kusano K, Watanabe T, Fukushima N, Doi T 2002 22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats. Nephrol Dial Transplant 17:2132-2137 (Pubitemid 35446668)
14. Kuhlmann A, Haas CS, Gross ML, Reulbach U, Holzinger M, Schwarz U, Ritz E, Amann K 2004 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 286:F526-F533 (Pubitemid 38233647)
15. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC 2008 Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 105:15896-15901
16. Deb DK, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y, Kong J, Shi H, Chang A, Li YC 2010 Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int 77:1000-1009
17. Li YC 2010 Renoprotective effects of vitamin D analogs. Kidney Int 78:134-139
18. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP 2002 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the reninangiotensin system. J Clin Invest 110:229-238 (Pubitemid 34787360)
19. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, Andress D 2010 Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376:1543-1551
20. de Boer IH, Kestenbaum B 2008 Vitamin D in chronic kidney disease: is the jury in? Kidney Int 74:985-987
21. 2011 Dietary reference intakes for calcium and vitamin D. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Washington, DC: The National Academies Press
22. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS 2007 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50:69-77 (Pubitemid 46962855)
23. de Boer IH, Katz R, Chonchol M, Ix JH, Sarnak MJ, Shlipak MG, Siscovick DS, Kestenbaum B 2011 Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol 6:2141-2149
24. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC 2007 Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:1063-1069 (Pubitemid 351664326)
25. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986
26. Agborsangaya C, Toriola AT, Grankvist K, Surcel HM, Holl K, Parkkila S, Tuohimaa P, Lukanova A, Lehtinen M 2010 The effects of storage time and sampling season on the stability of serum 25-hydroxyvitamin D and androstenedione. Nutr Cancer 62:51-57
27. Hoofnagle AN, Laha TJ, Donaldson TF 2010 A rubber transfer gasket to improve the throughput of liquid-liquid extraction in 96-well plates: application to vitamin D testing. J Chromatogr B Analyt Technol Biomed Life Sci 878:1639-1642
28. Strathmann FG, Laha TJ, Hoofnagle AN 2011 Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem 57:1279-1285
29. Bosworth CR, Levin G, Robinson-Cohen C, Hoofnagle AN, Ruzinski J, Young B, Schwartz SM, Himmelfarb J, Kestenbaum B, de Boer IH 2012 The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney Int 82:693-700
30. Phinney KW 2008 Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 88:511S-512S
31. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J 2009 A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612
32. Steffes M, Cleary P, Goldstein D, Little R, Wiedmeyer HM, Rohlfing C, England J, Bucksa J, Nowicki M 2005 Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem 51:753-758 (Pubitemid 40463927)
33. de Boer IH, Levin G, Robinson-Cohen C, Biggs ML, Hoofnagle AN, Siscovick DS, Kestenbaum B 2012 Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med 156:627-634
34. Joergensen C, Hovind P, Schmedes A, Parving HH, Rossing P 2011 Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care 34:1081-1085
35. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Fowlkes JL 2011 Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab 96:142-149
36. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G 2010 Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171:903-908